Gene therapy is back into play after a decade-long failed deliveries. 2017 was a golden year in gene therapy arena, various companies are aggressively developing gene therapy based treatments targeting life-threatening indications. Spark therapeutics got USFDA approval for the first-ever gene therapy based blindness treatment Luxturna. The therapy will help patients with a faulty gene in DNA i.e. RPE65 gene. The company will insert a functional RPE65 gene into the patients DNA to replace the defective gene resulting in vision restoration. It’s a one-time treatment with a hefty price tag of around USD 1 million making it a long shot for the patients. Luxturna got the approval last month and according to the spark therapeutics the treatment will cost around USD 425000 per injection excluding the cost of operation which will further add around USD 4000 – USD 5000 to the same. For justifying the hefty price tag spark therapeutics stated that “the cost for a lifetime of blindness including lost earnings and caregiver wages can easily exceed $1 million”. Being a breakthrough treatment based on gene therapy Luxturna surely is a hot topic in the pharmaceutical industry with experts analyzing the potential of the therapy and price associated with it.
DelveInsight Blog

VBL Therapeutics’ VB-111 (ofranergene obad...
May 03, 2022
FDA Grants Fast Track Designation to VB-111 for Platinium-resistant Ovarian Cancer The FDA has given VBL Therapeutics...

Top 12 Most Expensive Drugs in the US Heal...
Apr 20, 2022
Drug pricing is one of the hottest topics in the healthcare segment. Several arguments have been put forward by peopl...

What Does the Future Hold For Gene Therapy...
Feb 18, 2022
Duchenne Muscular Dystrophy (DMD) is a rare disorder, but it is one of the most common genetic conditions, affecting ...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU ...
Patent protection and expiration is one of the hot topics in the healthcare industry. P...
What are the Top 9 Most Common Food Allergies and How Pharma Companies are Ta...
Food Allergies is a major concern for a wide spectrum of populations globally. Accordin...
Evaluating the Top Players in the Global Bone Densitometers Market
Bone densitometers are the diagnostic systems with an enhanced X-ray technology known a...
Mapping the Biggest Pharmaceutical Companies by Continents
Today, the most important factor affecting the world’s economy is the Global Pharmaceut...
Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Develop...
It's no longer startling to learn that the best-performing surgeon at a hospital isn't ...
RECENT ARTICLES